Clinical Trials for Cellectis

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cellectis

Clinical Trials (3)

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

PHASE1/PHASE2Recruiting

80 participants

Started: Nov 1, 2022 · Completed: Aug 31, 2027

1 condition1 sponsor10 locations

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

PHASE1/PHASE2Recruiting

52 participants

Started: Oct 14, 2019 · Completed: Jun 30, 2026

1 condition1 sponsor19 locations

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

PHASE1Active, not recruiting

29 participants

Started: Jun 19, 2017 · Completed: Dec 31, 2025

1 condition1 sponsor8 locations